1475PDA randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide and cisplatin (API), followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). Update at 10 years. (18th September 2017) - Pautier, P.; Brard, C.; Floquet, A.; Gladieff, L.; Rios, M.; Piperno-Neumann, S.; Berton-Rigaud, D.; Blay, J-Y.; Fabbro, M.; Lotz, J-P.; Vinceneux, A.; Bertucci, F.; et al.